Metabolix, Inc. Share Price Nasdaq
Equities
US5910188821
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2024 * | 1.2M 93.86M | Sales 2025 * | 2.6M 203M | Capitalization | 610K 47.74M |
---|---|---|---|---|---|
Net income 2024 * | -9M -704M | Net income 2025 * | -11M -860M | EV / Sales 2024 * | 0.51 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.23 x |
P/E ratio 2024 * |
-0.09
x | P/E ratio 2025 * |
-0.08
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on Metabolix, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Oliver Peoples
FOU | Founder | 66 | 31/05/92 |
Charles Haaser
DFI | Director of Finance/CFO | 68 | 31/12/07 |
Kristi Snell
CTO | Chief Tech/Sci/R&D Officer | 56 | 31/12/96 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 30/09/06 | |
Richard Hamilton
BRD | Director/Board Member | 61 | 01/03/17 |
Oliver Peoples
FOU | Founder | 66 | 31/05/92 |
1st Jan change | Capi. | |
---|---|---|
+16.59% | 44.44B | |
+42.49% | 40.03B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.23% | 27.29B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |